Are Analysts Crazy? Price Targets Suggest 29% Jump In S&P 500.

• Analysts raised combined price targets by 0.9% even as the S&P 500 fell 6.8% from Feb. 25 through late March, showing continued optimism despite market weakness
• Eight of 11 S&P sectors recorded increased price targets while their actual prices declined, with only Energy showing both higher targets and higher performance
• Top expected gainers include Fair Isaac (90% upside to target), DoorDash (76%), and Microsoft (64%), with over 90% of analysts rating MSFT as buy/outperform despite its 34% drop from October highs

Market Summary: Analyst Price Targets Signal 29% S&P 500 Upside Despite Recent Decline

Key Market Data

Wall Street analysts maintain bullish outlooks despite recent market weakness, with median S&P 500 price targets reaching 8,349.36—representing a 28.9% increase from Thursday's close of 6,477.16. This optimism persists even as the market experiences its worst decline since last year's tariff announcements.

The S&P 500 has fallen 9% from recent highs, while the Nasdaq composite is down over 12% from its January peak. Between February 25 and late March, the S&P 500 declined 6.8%, yet combined analyst price targets actually rose 0.9%.

Sector Outlook

Technology stocks show the strongest expected performance with a projected 40.9% increase over 12 months. Energy is the only sector expected to decline, down 2.4% based on analyst targets. Eight of eleven S&P sectors saw increased price targets despite falling prices during the measurement period.

Top Individual Stock Targets

Ten S&P 500 companies show significant upside potential based on analyst consensus:

• Fair Isaac (FICO): 89.9% upside to $1,275
• DoorDash (DASH): 76% upside to $267.50 (currently 50% below October highs)
• Robinhood (HOOD): 70.6% upside (down 52% from all-time high)
• Microsoft (MSFT): 63.9% upside to $600 (fallen 34% from October high, with 90% of 60 analysts rating buy/outperform)

Market Implications

The divergence between current market conditions and analyst optimism raises questions about near-term market direction. IBD's market exposure recommendation stands at the lowest possible range of 0-20%, suggesting continued caution despite bullish long-term analyst forecasts.